Druggable genome in attention deficit/hyperactivity disorder and
$ 17.50
-
By A Mystery Man Writer
-
-
4.7(377)
Product Description
Potential Targets and Action Mechanism of Gastrodin in the Treatment of Attention-Deficit/Hyperactivity Disorder: Bioinformatics and Network Pharmacology Analysis
Potential Targets and Action Mechanism of Gastrodin in the Treatment of Attention-Deficit/Hyperactivity Disorder: Bioinformatics and Network Pharmacology Analysis
Higher rates of autism and attention deficit/hyperactivity disorder in American children: Are food quality issues impacting epigenetic inheritance?
Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome
Systematic Review: Molecular Studies of Common Genetic Variation in Child and Adolescent Psychiatric Disorders - Journal of the American Academy of Child & Adolescent Psychiatry
Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome
Linking GWAS to pharmacological treatments for psychiatric disorders
Unraveling the Link between Olfactory Deficits and Neuropsychiatric Disorders
Insights into attention-deficit/hyperactivity disorder from recent genetic studies, Psychological Medicine
March 2017 – The Science of Parkinson's
Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD
Frontiers Attention-deficit/hyperactive disorder updates
Role of MeCP2 in neurological disorders: current status and future perspectives
